Ervebo procurement
Active Definitive Contract Awarded Last action
- Contract number
- 75A50124C00057
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $156,033,983
Award facts
- Opportunity
-
- Notice of Intent to Sole Source: ERVEBO Special Notice · 75A50124R00001 · Posted Jul 9, 2024
- Contract value 90% obligated
-
- $156,033,983.00 Current, with exercised options
- $173,814,205.00 Potential, with all options
- Completion date 21% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Rahway, NJ 07065, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $190,468 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,843,515 | |
| Original award | $153,000,000 |
About this award
The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $173.8 million definitive contract to Merck Sharp & Dohme LLC for procurement of ERVEBO Zaire ebolavirus vaccine on September 30, 2024, on a sole-source basis.
Merck is the sole manufacturer of ERVEBO. The contract procures up to 1,000,000 licensed doses for the Strategic National Stockpile, along with vendor-managed inventory storage, dose expiry extension, and development of a new bioreactor-based manufacturing process. The contract carries a 120-month period of performance, extending through September 30, 2034, at a firm fixed price structure with a cost-plus-fixed-fee component.
Place of performance is Rahway, NJ. The originating solicitation, posted July 9, 2024, with a July 24 deadline, was published as a Special Notice reflecting BARDA's intent to sole-source the procurement to meet the Public Health Emergency Medical Countermeasures Enterprise requirement of 1,130,000 total doses.
Quick answers
Who was awarded contract 75A50124C00057?
75A50124C00057 was awarded to Merck Sharp & Dohme LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2024.
How much is contract 75A50124C00057 worth?
The government has obligated $156,033,983 on 75A50124C00057. Its potential value, with all options, is $173,814,205.
Was contract 75A50124C00057 competed?
The extent of competition for 75A50124C00057 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award